Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Joanna Gotfrit"'
Autor:
David J. Stewart, John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca A. C. Auer, Gerald Batist
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2453-2480 (2024)
Countries face challenges in paying for new drugs. High prices are driven in part by exploding drug development costs, which, in turn, are driven by essential but excessive regulation. Burdensome regulation also delays drug development, and this can
Externí odkaz:
https://doaj.org/article/e2a0bda42f934ee6ba8bb491b5743aa9
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1460-1469 (2024)
Canada has one of the most complex and rigorous drug approval and public reimbursement processes and is, unfortunately, one of the countries with the longest delays in drug access. To assess the overall impact of systemic delays in access to cancer t
Externí odkaz:
https://doaj.org/article/5b665a8d7a034e4c9ce8bfce931309c4
Autor:
Joanna Gotfrit, Ashley Jackson, John J. W. Shin, David J. Stewart, Ranjeeta Mallick, Paul Wheatley-Price
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1997-2007 (2022)
Background: Canada has a publicly funded healthcare system with a complex drug funding process. After Health Canada approval to market a drug, the pan-Canadian Oncology Drug Review (pCODR) (now renamed the CADTH reimbursement review) makes a non-bind
Externí odkaz:
https://doaj.org/article/8a837d33f3c34bb68ff9e244cd153e01
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 455-464 (2022)
Cancer treatment has evolved significantly over the past decade with the emergence of a multitude of new treatments across cancer types. Alongside the pace of drug discovery, the cost of cancer drugs has also increased. In the face of this growth in
Externí odkaz:
https://doaj.org/article/f98d343deb4c4c39b37e52347e92c419
Autor:
Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, Angela J. Hyde, Thierry Alcindor, Francine Aubin, Scott Berry, Dominick Bossé, Colin Brown, Ronald Burkes, Margot Burnell, Bruce Colwell, Jessica Corbett, Jeff Craswell, Nathalie Daaboul, Mark Doherty, D. A. Barry Fleming, Luisa Galvis, Rakesh Goel, Mohammed Harb, Alwin Jeyakumar, Derek Jonker, Erin Kennedy, Michael Lock, Aamer Mahmud, Patrick H. McCrea, Vimoj Nair, Rami Nassabein, Carolyn Nessim, Ravi Ramjeesingh, Muhammad Raza, Wissam Saliba, Satareh Samimi, Simron Singh, Stephanie Snow, Mustapha Tehfé, Michael Thirlwell, Mario Valdes, Stephen Welch, Michael Vickers
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 1988-2006 (2021)
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management
Externí odkaz:
https://doaj.org/article/4fa09d7c1ccc49218dd9a019789f6534
Autor:
Shaan Dudani, Horia Marginean, Patricia A. Tang, Jose G. Monzon, Soundouss Raissouni, Timothy R. Asmis, Rachel A. Goodwin, Joanna Gotfrit, Winson Y. Cheung, Michael M. Vickers
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background A standard therapy for locally advanced rectal cancer (LARC) includes fluoropyrimidine (FP)-based neoadjuvant chemoradiation (nCRT). Previous studies have inconsistently demonstrated that baseline neutrophil- and platelet-to-lymph
Externí odkaz:
https://doaj.org/article/053b34ad89474af9a1b3eacd5edcdda6
Autor:
Esmeralda C. Marginean, Joanna Gotfrit, Horia Marginean, Daniel W. Yokom, Justin J. Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek Jonker, Timothy Asmis, Rachel A. Goodwin
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100996- (2021)
Background: Signal Transducer and Activator of Transcription-3 (STAT3) mediates cellular functions. We assessed the IHC expression of phosphorylated STAT3 (pSTAT3) in paired primary tumors and liver metastases in patients with advanced stage colorect
Externí odkaz:
https://doaj.org/article/f0006ae798894edfa766a8a21f95b1c6
Autor:
Joanna Gotfrit, Tharshika Thangarasa, Shaan Dudani, Rachel Goodwin, Patricia A. Tang, Jose Monzon, Kristopher Dennis, Winson Y. Cheung, Horia Marginean, Michael Vickers
Publikováno v:
Public Health in Practice, Vol 1, Iss , Pp 100012- (2020)
Objectives: Cancer patients experience disparities due to socioeconomic status (SES) factors. We assessed the impact of SES factors on outcomes in patients with locally advanced rectal cancer (LARC) who received neoadjuvant chemoradiation (nCRT) and
Externí odkaz:
https://doaj.org/article/5b1f4fdb70a04e88b5c4796856c0acc4
Autor:
Sam Babak, Patricia A. Tang, Michael M. Vickers, Joanna Gotfrit, Horia Marginean, Winson Y. Cheung, Kristopher Dennis, Hagen F. Kennecke, Jose Gerard Monzon, Erin Diana Powell, Shaan Dudani
Publikováno v:
Diseases of the Colon and Rectum
BACKGROUND: Patients with chronic kidney disease are commonly excluded from clinical trials. The impact of chronic kidney disease on outcomes in patients with locally advanced rectal cancer has not been previously studied. OBJECTIVE: This study aimed
Autor:
Scott R. Berry, Stephanie Snow, Alwin Jeyakumar, Ravi Ramjeesingh, Carolyn Nessim, Timothy R. Asmis, Patrick H McCrea, Jeff Craswell, Satareh Samimi, Mark Doherty, Mario Valdes, Jessica Corbett, Rachel Anne Goodwin, M. Vickers, Dominick Bossé, Thierry Alcindor, Francine Aubin, Erin D. Kennedy, Aamer Mahmud, Angela J Hyde, Michael Lock, Rami Nassabein, Margot J. Burnell, Simron Singh, Wissam Saliba, Derek J. Jonker, Mustapha Tehfe, Luisa Galvis, M. Thirlwell, Rakesh Goel, Vimoj Nair, Mohammed Harb, Ronald Burkes, Colin Brown, Muhammad Asim Raza, Joanna Gotfrit, Nathalie Daaboul, D A Barry Fleming, Stephen Welch, B. Colwell
Publikováno v:
Current Oncology, Vol 28, Iss 185, Pp 1988-2006 (2021)
Current Oncology
Current Oncology
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management